Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why Should I Continue My Investment In PTSC

According to the PTSC bulletin board the " USPTO indicates it will issue a Reexamination Certicate for the US "336" patent". this announcement was make back in Sept. 09. When can we expect the USPTO to in fact confirm this "indication".

Share
New Message
Please login to post a reply